OMNIQ Corp. (OMQS) Q3 2024 Earnings Call Transcript Summary
OMNIQ Corp. (OMQS) Q3 2024 Earnings Call Transcript Summary
The following is a summary of the OMNIQ Corp. (OMQS) Q3 2024 Earnings Call Transcript:
以下是OMNIQ公司(OMQS)2024年第三季度業績會通訊的摘要:
Financial Performance:
財務表現:
Revenue increased to $18.5 million, a 7.6% increase from $17.2 million in Q3 2023.
Operating expenses decreased by approximately 26%, from $6.6 million in Q3 2023 to $4.9 million in Q3 2024.
Net loss decreased by approximately 63% from $4.3 million in Q3 2023 to $1.6 million in Q3 2024.
Gross profit slightly decreased to $3.95 million in Q3 2024 from $4 million in Q3 2023.
Basic loss per share improved to negative $0.15 in Q3 2024 from negative $0.55 in Q3 2023.
營業收入增加至1850萬,較2023年第三季度的1720萬增長7.6%。
營業費用減少約26%,從2023年第三季度的660萬降至2024年第三季度的490萬。
淨虧損從2023年第三季度的430萬減少約63%,降至2024年第三季度的160萬。
毛利潤略微減少,從2023年第三季度的400萬降至2024年第三季度的395萬。
基本每股虧損改善至2024年第三季度的負0.15,較2023年第三季度的負0.55有所改善。
Business Progress:
業務進展:
Selected by NEC for a project using proprietary technology for facial recognition at critical checkpoints.
Advanced access control technology deployed in two medical centers.
Expanded Fintech offerings through partnerships, expecting to launch a new version in the U.S. in 2025.
Received large purchase orders between $1 and $3.4 million for IoT business, indicating trust from existing customers.
Diversified hardware sources to minimize supply chain risks, enhancing margin stability.
被NEC選中,進行一個使用專有技術的人臉識別項目,應用於關鍵檢查點。
愛文思控股的訪問控制技術在兩個醫療中心部署。
通過合作伙伴關係擴展金融科技產品,預計在2025年在美國推出新版本。
收到價值在$1到340萬的物聯網業務大額訂單,顯示出現有客戶的信任。
多樣化硬件來源以最小化供應鏈風險,增強利潤穩定性。
Opportunities:
機會:
Projected growth in AI-driven supply chain and public safety solutions with increased investment in automation and smart city projects.
Expanding market presence in smart city infrastructure, public safety, logistics, and healthcare sectors.
預計在人工智能驅動的供應鏈和公共安全解決方案中增長,增加對自動化和智慧城市項目的投資。
在智慧城市基礎設施、公共安全、物流和醫療衛生領域擴展市場影響力。
Risks:
風險:
No explicit risks/opportunities detected.
未檢測到明確的風險/機會。
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示:如需更全面的詳情,請參閱投資人關係網站。本文僅供投資者參考,不作任何指引或建議。
譯文內容由第三人軟體翻譯。